NEW YORK (GenomeWeb News) — Pressure BioSciences said in a filing with the US Securities and Exchange Commission yesterday that it has reached a settlement with institutional investor Redwood Management related to a convertible debenture purchase made in mid-2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.